This fundamental difference introduces a degree of uncertainty that is incompatible with safe medical care
[PMID: 15557875] PubMed record related to this compound for laboratory literature review
The question of how long to stay on GLP-1 therapy takes on new dimensions when you factor in organ protection beyond weight maintenance
Achieving over 10% weight loss is associated with clinically significant reductions in risk of chronic conditions such as type 2 diabetes and heart disease
Check out this study: adaptation of colonic fermentation and GLP-1 secretion with increased fiber intakefor not a few hours but an entire year

Possible clinical applications for elevated glutathione levels Neurology Parkinsons disease Alzheimers disease Seizures Multiple sclerosis Eye diseases Cataracts Macular degeneration Glaucoma Cardiovascular Prevent heart disease Prevent stroke Prevent atherosclerosis Prevent reperfusion injury Digestive system Inflammatory bowel disease Hepatitis Malnutrition Pancreatitis Peptic Ulcer Toxicology Certain drug overdoses Tobacco smoke, auto exhaust Pollutants including heavy metals, pesticides Prevents hearing loss from noise pollution Detoxifies many well-known carcinomas Infectious disease and immunology Anti-viral (AIDS, hepatitis, herpes, common cold, etc.) Bacterial Infection Certain autoimmune dysfunction Chronic fatigue syndrome Immunosuppression Cancer Cancer prevention Suppress tumor growth Eliminate Carcinogens, mutagens Retard oxidative damage to DNA Prevent wasting disease Ease side effects of chemo- and radiotherapy Pulmonary Break up mucus (esp